Nyxoah SA

NYXH · NYSE

$0.8344+$0.0124 (+1.51%)TodayMarket closed ·
Prev close $0.822

Latest news

  • NewsAvi Kapoor

    Why RingCentral Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket

  • News

    Nyxoah Reports Preliminary Q3 Global Net Sales Of ~€9.2M, Up 19% QoQ; Lowers FY26 Global Net Sales From €36M-€40M To €33M-€35M

  • Press releaseGlobe Newswire

    Nyxoah Announces Preliminary Results for the Third Quarter of 2026 and Adjusts Revenue Guidance for 2026

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • Press releaseGlobe Newswire

    Nyxoah Reports Second Quarter and First Half 2026 Financial and Operating Results

  • Press releaseGlobe Newswire

    Nyxoah to Release Second Quarter 2026 Financial Results on August 5, 2026

  • Press releaseGlobe Newswire

    Nyxoah Announces Preliminary Results for the Second Quarter of 2026

  • Press releaseGlobe Newswire

    Nyxoah Announces Closing of Underwritten Public Offering

  • NewsVandana Singh

    What's Going On With Nyxoah Stock Tuesday?

  • Press releaseGlobe Newswire

    Nyxoah Announces Pricing of $95 Million Underwritten Public Offering

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    Nyxoah Announces Proposed Offering of Ordinary Shares

  • News

    Nyxoah Reports Q1 2026 Results: Full Earnings Call Transcript

  • Press releaseGlobe Newswire

    Nyxoah Reports First Quarter 2026 Financial and Operating Results

  • News

    Earnings Scheduled For May 12, 2026

  • Press releaseGlobe Newswire

    Nyxoah's Genio® Therapy Receives Significant 2026 Medicare Reimbursement Increases Under Final CMS Rule

  • Press releaseGlobe Newswire

    Nyxoah to Participate in the Stifel 2025 Healthcare Conference

  • Press releaseGlobe Newswire

    Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025

  • Press releaseGlobe Newswire

    Nyxoah Announces First U.S. Commercial Patients Implanted with Genio® System

  • Press releaseGlobe Newswire

    Nyxoah Provides an Update on Expanded Middle East Presence

  • Press releaseGlobe Newswire

    Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.

  • NewsChris Katje

    Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. – NYXH

  • News

    Examining the Future: Nyxoah's Earnings Outlook

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • News

    Market-Moving News for April 8th

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseBusiness Wire

    NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

  • Press releaseBusiness Wire

    NYXH Investors Have Opportunity to Join Nyxoah S.A. Fraud Investigation with the Schall Law Firm

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • Press releaseGlobe Newswire

    Nyxoah S.A. Investors: Company Investigated by the Portnoy Law Firm

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nyxoah S.A. - NYXH

  • NewsAvi Kapoor

    Tesla, A. O. Smith And Other Big Stocks Moving Lower In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.